{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:34Z","timestamp":1787065354419,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1972,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.fertnstert.2016.09.023","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T14:18:04Z","timestamp":1477577884000},"page":"253-260.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin\/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-4009","authenticated-orcid":false,"given":"Karen E.","family":"Elkind-Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka L.","family":"Seidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh C.","family":"Gutowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.09.023_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib2","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib4","unstructured":"National Institutes of Health. National Institutes of Health Evidence-based Methodology Workshop on Polycystic Ovary Syndrome, December 3-5 2012. Available at: https:\/\/prevention.nih.gov\/docs\/programs\/pcos\/finalreport.pdf. Accessed June 1, 2016."},{"key":"10.1016\/j.fertnstert.2016.09.023_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib6","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched reference controls: a retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib11","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib12","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implication for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib14","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose tolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib15","first-page":"1241","article-title":"Defects in beta-cell function in functional ovarian hyperandrogenism","volume":"76","author":"O\u2019Meara","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/1389450115666140311102638","article-title":"Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment","volume":"15","author":"Janardhan","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib19","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib21","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0015-0282(16)45254-4","article-title":"Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients","volume":"35","author":"Mathur","year":"1981","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2016.09.023_bib24","first-page":"4","article-title":"Position statement. Standards of medical care in diabetes-2013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.313.7056.559d","article-title":"Ratio of waist circumference to height is strong predictor of intra-abdominal fat","volume":"313","author":"Ashwell","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u00df-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-5491.1995.tb00399.x","article-title":"The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion","volume":"12","author":"Wareham","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib30","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/eje.0.1500097","article-title":"Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess \u03b2 cell function in clinical studies","volume":"150","author":"Ahren","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","article-title":"Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test","volume":"16","author":"Retnakaran","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib34","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib35","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4158\/EP11375.OR","article-title":"Pancreatic \u00df-cell dysfunction in polycystic ovary syndrome: the role of metformin","volume":"18","author":"Messer","year":"2012","journal-title":"Endocrin Pract"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib37","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1463-1326.2006.00698.x","article-title":"Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes","volume":"9","author":"Rosenstock","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.fertnstert.2006.11.133","article-title":"Comparison of two doses of metformin (2.5 and 1.5 g\/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference","volume":"88","author":"Bruno","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.09.023_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2014a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"Br J Ob Gyn"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216628431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T02:42:32Z","timestamp":1666492952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216628431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0015028216628431"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin\/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}